ResMed | RMD - Ebitda

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 32.69B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	Ebitda	更改		日
Ansell	USD 185.8M		7M	2025-12
Artivion	USD 22.72M		1.84M	2025-12
AtriCure	USD 27.28M		10.21M	2026-06
Baxter International	USD 309M		756M	2026-03
Cochlear	AUD 306.4M		13.5M	2025-12
Cooper Companies	USD 323.4M		13.2M	2025-12
CSL	USD 3.13B		1.17B	2025-12
Dexcom	USD 364.5M		57.7M	2026-03
Edwards Lifesciences	USD 555.6M		485.5M	2026-03
Fisher Paykel Healthcare	NZD 434M		70M	2026-06
Globus Medical	USD 279.84M		48.01M	2026-06
Haemonetics	USD 96.17M		91.87M	2026-06
Idexx Laboratories	USD 468.46M		67.59M	2026-06
Insulet	USD 199.8M		18.1M	2026-06
Integra LifeSciences	USD 78.41M		2.23M	2026-06
Intuitive Surgical	USD 1.06B		29.9M	2026-03
Medtronic	USD 2.81B		119M	2026-03
Philips	EUR 910M		343M	2026-06
Ramsay Health Care	AUD 1.12B		10.6M	2025-12
ResMed	USD 559.78M		9.06M	2026-06
Sigma Healthcare	AUD 19.96M		5.15M	2024-07
Sonic Healthcare	AUD 839.07M		51.09M	2024-12
Steris	USD 443M		48.3M	2026-03
Teleflex	USD 75.63M		171.44M	2026-03
Thermo Fisher Scientific	USD 3.55B		845M	2026-06